CD20- and CD56-positive T-cell large granular lymphocyte leukemia in a human T-cell leukemia virus type 1 carrier

Sonoko Nakano-Akamatsu1, Ryoichi Takahashi, Yukiko Sekioka

  • 1Department of Hematology, Omihachiman Community Medical Center, Omihachiman Shiga 523-0082, Japan. naoaki-akamatsu@nifty.com

Insights

This study reports a unique case of T-cell granular lymphocyte (T-LGL) leukemia in a patient who was positive for human T-cell leukemia virus type 1 (HTLV-1). Despite HTLV-1 positivity, the virus did not appear to cause the leukemia.

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • T-cell granular lymphocyte (T-LGL) leukemia is a rare lymphoproliferative disorder.
  • Human T-cell leukemia virus type 1 (HTLV-1) is associated with certain hematologic malignancies.

Observation:

  • A 60-year-old man presented with asymptomatic T-LGL leukemia.
  • The patient was serologically positive for HTLV-1.
  • Monoclonal HTLV-1 integration was not detected in peripheral blood.

Findings:

  • The neoplastic T-cells exhibited a unique phenotype: CD3+, CD4+, CD8+, CD16-, CD56+, CD57+, TCR alphabeta+, and weak CD20 coexpression.
  • HTLV-1 was not implicated in the pathogenesis of T-LGL leukemia in this specific case.

Implications:

  • This case highlights the importance of comprehensive phenotypic analysis in T-LGL leukemia.
  • It suggests that HTLV-1 seropositivity does not always correlate with viral involvement in T-LGL leukemia pathogenesis.
  • Further research may elucidate the complex interplay between viral infections and T-LGL leukemia development.